A phase 3 multicentre randomised sham controlled study to determine the safety and efficacy of Renexus in Mactel Telangiectasia type 2.
A not for profit organisation
A not for profit organisation
A phase 3 multicentre randomised sham controlled study to determine the safety and efficacy of Renexus in Mactel Telangiectasia type 2.
If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.
